News & Commentaries

|

Surprising Research Result: All Immature Cells Can Develop into Stem Cells

Copenhagen, Denmark – New sensational study conducted at the University of Copenhagen disproves traditional knowledge of stem cell development. The study reveals that the destiny of intestinal cells is not predetermined, but instead determined by the cells' surroundings. The new knowledge may make it easier to manipulate stem cells for stem cell therapy. The results have just been published in Nature.

|

Scientists Grow Precursors For Human Pigment Cells

kobe news

Kobe, Japan – Our hair, skin and eyes are colored by a pigment called melanin, which is produced by pigment cells called melanocytes. Scientists have used stem cell technology to successfully create melanocyte precursor cells. These cells can be used in research on melanoma and other pigment cell-related illnesses. The findings were published on March 6 in the online edition of Pigment Cell & Melanoma Research.

|

Tissue Engineering Applications Combining Biomaterial Scaffolds with Stem Cells Will Facilitate Delivery of Targeted Therapies

STJ PR
Noted stem cell researchers present a state-of-the-art review in the inaugural article published in StemJournal

Amsterdam, NL – StemJournal, a new open access, peer-reviewed journal published by IOS Press, announces publication of its inaugural article, "Combining Stem Cells and Biomaterial Scaffolds for Constructing Tissues and Cell Delivery" by Stephanie M. Willerth, PhD, and Shelly E. Sakiyama-Elbert, PhD. This timely overview of the available biomaterials for directing stem cell differentiation as a means of producing replacements for diseased or damaged tissues is a comprehensive update of the classic review published in StemBook in 2008.

|

Study Reveals Factors Behind Embryonic Stem Cell State

monash news

Monash, Australia – Embryonic stem cells (ESC) have the ability to self-renew, and, being pluripotent have the potential to create almost any cell type in the body. The embryonic stem cell state is established and maintained by multiple regulatory networks that include epigenetic regulators; the function of these epigenetic regulators though has not been well-defined.

|

Boosting Muscle Stem Cells to Treat Muscular Dystrophy and Aging Muscles

SBP news

La Jolla, CA, USA – Lying within our muscles are stem cells, invisible engines that drive the tissue’s growth and repair. Understanding the signal(s) that direct muscle stem cells to spring into action could uncover new ways to promote muscle growth. However, these mechanisms are poorly understood.

|

Scientists "Reverse Engineer" Brain Cancer Cells to Find New Targets for Treatment

UoT/sickkids news
Genome-wide CRISPR-Cas9 screens expose vulnerabilities in patient-derived glioblastoma stem cells

Toronto, Canada – Glioblastoma is one of the most devastating forms of cancer, with few existing treatment options. It is also a leading cause of cancer-related death in children and young adults. Scientists have "reverse engineered" brain cancer stem cells gene by gene, uncovering multiple potential targets for this hard-to-treat cancer.

|

New Study Explains How Inflammation Causes Gastric Cancer

kanazawa news

Kinazawa, Japan – Researchers from Kanazawa University and the Japan Agency for Medical Research and Development have solved the decades-old mystery of how stomach bacterium Helicobacter pylori causes gastric cancer. Using mouse models and human cancer cell lines, they showed that inflammation resulting from bacterial infection leads to the proliferation of gastric epithelial cells, which ultimately form gastric tumors. By blocking the protein pathway responsible for this proliferation, they prevented gastric tumor formation.

|

Discovery of "Kingpin" Stem Cell May Help in the Understanding of Cancerous Tumors

mcmaster news

Hamilton, ON, Canada – A team of McMaster researchers has discovered a unique subset of cells within human stem cells that appear to signal how the surrounding cells will develop and grow. The discovery of these "kingpin" cells, named human pluripotent founder cells, along with the process of identifying the cells, is expected to open a new channel of research aimed at better understanding the growth of cancerous tumours and how human stem cells make decisions on what to become or not become. The study was published in Cell.

|

Shutting Down Deadly Pediatric Brain Cancer at Its Earliest Moments

StemBook; Shutting Down Deadly Pediatric Brain Cancer at Its Earliest Moments
Study uses cell-by-cell analyses to look for new therapies

Cincinnati, OH, USA – Cell-by-cell genetic analyses of developing brain tissues in neonatal mice and laboratory models of brain cancer allowed scientists to discover a molecular driver of the highly aggressive, deadly, and treatment-resistant brain cancer, glioblastoma

|

Mutation Human iPSC-Derived MSCs from Aged Individuals Acquire a Rejuvenation Signature

StemBook; Mutation Human iPSC-Derived MSCs from Aged Individuals Acquire a Rejuvenation Signature

Dusseldorf, Germany – The use of primary mesenchymal stem cells (MSCs) is fraught with ageing-related shortfalls such as limited expansion and early senescence. Human induced pluripotent stem cells (iPSCs) – derived MSCs (iMSCs) – have been shown to be a useful clinically relevant source of MSCs that circumvent these ageing-associated drawbacks. The importance of this concept is manifested by the successful Phase 1 clinical trial for the treatment of GvHD by Cynata Therapeutics and the National Health Service- UK; a Phase 2 trial is planned for 2019. (Note: This trial is independent of the work carried out by Spitzhorn et al. described in this release.)

Pages